Kisho

Rare disease intelligence. Free for every patient.

Rare Disease Intelligence, Weekly

AI-curated news across pipeline, policy, funding, and research.

Italfarmaco SpA — Rare Disease Pipeline | Kisho

Italfarmaco SpA

Other

0

Orphan Designations

0

FDA Approvals

0

Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.

Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA

No pipeline data available yet.